In this review we provide a conceptual overview of radiopharmaceuticals containing positron-
emitting isotopes, not a catalog of radiopharmaceuticals or details of syntheses. We hope to …

Non-Invasive Radiotracer Imaging (NIRI) uses either short-lived positron-emitting isotopes,
such as 11 C and 18 F, for Positron Emission Tomography (PET) or single photon emitting …

Aims Cold stress has been shown to produce dramatic increases in 2-fluoro-2-deoxy-D-
Glucose (18 FDG) accumulation by brown adipose tissue (BAT) in rodents. However, neither …

This study describes the radiosynthesis and preliminary biologic evaluation of trans-9 (RS)-
18F-fluoro-3, 4 (RS, RS)-methyleneheptadecanoic acid (18F-FCPHA) as a new potential …

The present invention relates to novel modified fatty acid analogs, where a positron or
gamma-emitting label is placed at a position on a fatty acid backbone and an organic …

(BMIPP), we examined the correlation between myocardial BMIPP uptake and blood levels
of free fatty acid (FFA), glucose, insulin, triglycé rideand total cholesterol. Methods: In 180 …

Abstract The potential of [1-11 C] hexanoate (11 C-HA) as a radiopharmaceutical assessing
fatty acid metabolism of the myocardium and brain tissues by PET studies was evaluated. 11 …

The present invention provides novel imaging agents for clinical diagnosis of injuries and
diseases, in the form of a radionuclide in spatial proximity to a substantially pure …

To evaluate the potential of [1-11C]-3-(R, S)-methyloctanoate (BMOA),[1-11C]-2-octynoate,
and [1-11C]-2-decynoate as PET tracers for studying particular steps in fatty acid β …

The present invention relates to novel modified fatty acid analogs, where a positron or
gamma-emitting label is placed at a position on a fatty acid backbone and an organic …